In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...

Biotech innovator Denali Therapeutics opened a new manufacturing hub as it develops new therapies for conditions like Hunter ...

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

At one point during her health journey, Chandler resident Erin Kienlen thought she had amyotrophic lateral sclerosis, or ALS.

ALS, or amyotrophic lateral sclerosis, is a fatal neurodegenerative disease that gradually robs individuals of their ability to walk, talk, eat, and eventually breathe.

A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link ...

Amyotrophic lateral sclerosis (ALS), also known as Lou ... of life expectancy after diagnosis and there is currently no cure for the disease. Sources: Lancet.2022 Oct 15;400(10360); EurJNeurol.

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

announced clinical results from treating a patient with ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease) with TRE-515 under the FDA Expanded Access program. TRE-515 ...